scholarly article | Q13442814 |
P50 | author | Matejka Rebolj | Q47497295 |
Marjolein van Ballegooijen | Q47497320 | ||
Caspar W N Looman | Q114515684 | ||
P2093 | author name string | Matejka Rebolj | |
Dik Habbema | |||
Rob Boer | |||
Joost van Rosmalen | |||
Theo Helmerhorst | |||
P2860 | cites work | Cancer free survival after CIN treatment: comparisons of treatment methods and histology | Q33272895 |
Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study | Q33444450 | ||
Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study | Q34137284 | ||
Invasive carcinoma of the uterine cervix following diagnosis and treatment of in situ carcinoma. Record linkage study within a National Cancer Registry | Q35623938 | ||
Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study. | Q36168904 | ||
Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia | Q36311966 | ||
Low risk of cervical cancer during a long period after negative screening in the Netherlands | Q36646749 | ||
Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. | Q36853587 | ||
Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study | Q37137085 | ||
Incidence of cervical cancer after several negative smear results by age 50: prospective observational study | Q37169635 | ||
Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2 | Q37223672 | ||
Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries | Q37291430 | ||
Development of a record linkage protocol for use in the Dutch Cancer Registry for Epidemiological Research | Q38478798 | ||
Natural history of cervical intraepithelial neoplasia: a critical review. | Q40891994 | ||
Re: Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study. | Q42588909 | ||
Cervical intraepithelial neoplasia and higher long term risk of cancer | Q42734671 | ||
A simple method to calculate the confidence interval of a standardized mortality ratio (SMR) | Q44817435 | ||
Cervical cancer screening policies and coverage in Europe | Q45177500 | ||
Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study. | Q51036686 | ||
Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. | Q53304855 | ||
Human papillomavirus triage of women with persistent borderline or mildly dyskaryotic smears: Comparison of costs and side effects of three alternative strategies | Q61881604 | ||
Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands | Q79387831 | ||
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial | Q81404025 | ||
ACOG Practice Bulletin no. 109: Cervical cytology screening | Q82793091 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | cervix uterine cancer | Q160105 |
cervical intraepithelial neoplasia | Q196788 | ||
P304 | page(s) | e6855 | |
P577 | publication date | 2012-10-31 | |
P1433 | published in | The BMJ | Q546003 |
P1476 | title | Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study | |
P478 | volume | 345 |
Q55312818 | Analysis of differential gene expression caused by cervical intraepithelial neoplasia based on GEO database. |
Q98893916 | Biomarkers of progression to oral cancer in patients with dysplasia: A systematic review |
Q38184467 | Condom use in prevention of Human Papillomavirus infections and cervical neoplasia: systematic review of longitudinal studies |
Q43434358 | Factors affecting compliance in the first year of postcolposcopy surveillance among women with a high incidence of cervical cancer. |
Q35768850 | Long-Term Clinical Outcome after Treatment for High-Grade Cervical Lesions: A Retrospective Monoinstitutional Cohort Study |
Q40995859 | Long-term costs of introducing HPV-DNA post-treatment surveillance to national cervical cancer screening in Ireland |
Q40771931 | Long-term follow-up of the risk for cervical intraepithelial neoplasia grade 2 or worse in HPV-negative women after conization |
Q47346188 | Long-term risk of cervical cancer following conization of cervical intraepithelial neoplasia grade 3-A Danish nationwide cohort study |
Q49320850 | Low recurrence rate of high-grade cervical intraepithelial neoplasia after successful excision and routine colposcopy during follow-up. |
Q39427415 | Prevalence of cervical intraepithelial neoplasia (CIN) in patients attending Minia Maternity University Hospital |
Q33626255 | Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trial |
Q55472638 | TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial. |
Q92887112 | The risk of cervical cancer after cervical intraepithelial neoplasia grade 3: A population-based cohort study with 80,442 women |
Q38133612 | Understanding HPV tests and their appropriate applications |
Search more.